clinical trial: Is anyone in rolled or... - Cure Parkinson's

Cure Parkinson's

26,300 members27,658 posts

clinical trial

9 Replies

Is anyone in rolled or thinking about trail in gene therapy CERE 120

Read more about...
9 Replies
Jeni profile image
Jeni

I have never heard of it Anthony???? Where did you find this one???

in reply to Jeni

This is being offered at Rush in Chicago

Ceregene Inc., a biotechnology company developing treatments for neurodegenerative diseases such as Parkinson's disease, will present new data demonstrating long-term, biologically-active expression of neurturin, a nervous system growth factor delivered to the degenerating dopamine nerves in patients with Parkinson's disease following treatment with CERE-120 (AAV2-neurturin).  Raymond T. Bartus, Ph.D., Ceregene's chief scientific officer and executive vice president, was invited to give a presentation entitled "The Development of AAV2-neurturin (CERE-120) for Parkinson's Disease: A Review of the Challenges and Translation Issues Confronted During the Course of Establishing 'Clinical Proof of Concept,'" at the annual meeting of the American Society for Gene and Cell Therapy during the Clinical Trials I Symposium on Thursday, May 17, 2012 in Philadelphia, PA.  CERE-120 is a viral vector engineered to deliver the nervous system growth factor neurturin (NRTN), which has the ability to rejuvenate degenerating dopamine-producing neurons, restoring function and keeping them alive.  NRTN has been shown to safely protect and restore damaged nigrostriatal nerves in animal models of Parkinson's disease and appears safe in humans tested in four Ceregene-sponsored clinical studies enrolling a total of 120 patients, 80 of whom were administered CERE-120.  A previous double blind-controlled human study demonstrated clinical benefit on several motor and Quality of Life (QOL) endpoints 12 and 18 months following CERE-120 delivery (with no measure favoring sham) and established clinical proof of concept in humans. 

Continued on Next page >>

Posted in: Drug Trial News | Medical Condition News

Tags: Alzheimer's Disease, Biotechnology, Brain, Cell, Dopamine, Gene, Nervous System, Parkinson's Disease, Protein, Putamen, Viral Vector, Virus

Jeni profile image
Jeni

Thanks, so how do we sign up for it?

in reply to Jeni

Rush Hospital Chicago

Jeni profile image
Jeni

I actually found the email for it and requested to be in the study. Thanks....

in reply to Jeni

Good luck I wanted to in this one but can't .

Jeni profile image
Jeni

Why can't you? They had 3 or 4 different ones...

in reply to Jeni

I had surgery in September of 2011 in Boston using GAD gene therapy.

Not what you're looking for?

You may also like...

Clinical trial

Just started my third trial here in Chicago Rush Hopital ! This one checks if Parkisons comes from...

Clinical Trial Update

I wanted to give this forum an update on my participation in the clinical trial at the University...

Buntanetap Clinical Trial

Is anyone participating at this trial, or knows someone that is. What's the lastest news. Are any...

Stemregen in clinical trial

There is a clinical trial in Spain researching the efficace of Stemregen natural caps in PD....

Light Therapy Clinical Trial

For those who might be interested, I received the message below from PhotoPharmics today providing...